Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

MLA

Adam S. Cheifetz, and Konstantinos Papamichael. “Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.” Clinical Gastroenterology and Hepatology, vol. 19, Apr. 2021, pp. 854–55. EBSCOhost, https://doi.org/10.1016/j.cgh.2020.04.088.

APA

Adam S. Cheifetz, & Konstantinos Papamichael. (2021). Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 19, 854–855. https://doi.org/10.1016/j.cgh.2020.04.088

Chicago

Adam S. Cheifetz, and Konstantinos Papamichael. 2021. “Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.” Clinical Gastroenterology and Hepatology 19 (April): 854–55. doi:10.1016/j.cgh.2020.04.088.